Header image
Frydrych Ivo Ph.D.
Postdoctoral training
Status: Ongoing.
About me
Researcher experienced in the field of cellular biology, microscopy, and flow cytometry with the main focus on studying the mechanism of action of newly synthesized cytotoxic compounds as potential anticancer drugs. GMO advisor at IMTM. Published >25 scientific papers and books/chapters, >312 SCI citations, H-index 10.
Journals
The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression. Molecular Medicine Reports. 2022, 26(4), 321, ISSN: 1791-2997, PMID: 36043519,
Substituted dienes prepared from betulinic acid - Synthesis, cytotoxicity, mechanism of action, and pharmacological parameters. European Journal of Medicinal Chemistry. 2021, 224, 113706, ISSN: 0223-5234, PMID: 34311159,